Distinct roles of Bcl-2 and Bcl-Xl in the apoptosis of human bone marrow mesenchymal stem cells during differentiation
- PMID: 21589877
- PMCID: PMC3093403
- DOI: 10.1371/journal.pone.0019820
Distinct roles of Bcl-2 and Bcl-Xl in the apoptosis of human bone marrow mesenchymal stem cells during differentiation
Abstract
Background: Adult mesenchymal stem cells (MSCs) can be maintained over extended periods of time before activation and differentiation. Little is known about the programs that sustain the survival of these cells.
Principal findings: Undifferentiated adult human MSCs (hMSCs) did not undergo apoptosis in response to different cell death inducers. Conversely, the same inducers can readily induce apoptosis when hMSCs are engaged in the early stages of differentiation. The survival of undifferentiated cells is linked to the expression of Bcl-Xl and Bcl-2 in completely opposite ways. Bcl-Xl is expressed at similar levels in undifferentiated and differentiated hMSCs while Bcl-2 is expressed only in differentiated cells. In undifferentiated hMSCs, the down-regulation of Bcl-Xl is associated with an increased sensitivity to apoptosis while the ectopic expression of Bcl-2 induced apoptosis. This apoptosis is linked to the presence of cytoplasmic Nur 77 in undifferentiated hMSCs.
Significance: In hMSCs, the expression of Bcl-2 depends on cellular differentiation and can be either pro- or anti-apoptotic. Bcl-Xl, on the other hand, exhibits an anti-apoptotic activity under all conditions.
Conflict of interest statement
Figures






Similar articles
-
Apoptotic regulation in primitive hematopoietic precursors.Blood. 1998 Sep 15;92(6):2041-52. Blood. 1998. PMID: 9731062
-
The effect of estrogen on bone marrow-derived rat mesenchymal stem cell maintenance: inhibiting apoptosis through the expression of Bcl-xL and Bcl-2.Stem Cell Rev Rep. 2012 Jun;8(2):393-401. doi: 10.1007/s12015-011-9292-0. Stem Cell Rev Rep. 2012. PMID: 21710144
-
Bcl-XL is qualitatively different from and ten times more effective than Bcl-2 when expressed in a breast cancer cell line.BMC Cancer. 2006 Aug 23;6:213. doi: 10.1186/1471-2407-6-213. BMC Cancer. 2006. PMID: 16928273 Free PMC article.
-
The Bcl-xL and Bax-alpha control points: modulation of apoptosis induced by cancer chemotherapy and relation to TPCK-sensitive protease and caspase activation.Biochem Cell Biol. 1997;75(4):301-14. Biochem Cell Biol. 1997. PMID: 9493953 Review.
-
Non-canonical roles of Bcl-2 and Bcl-xL proteins: relevance of BH4 domain.Carcinogenesis. 2017 Jun 1;38(6):579-587. doi: 10.1093/carcin/bgx016. Carcinogenesis. 2017. PMID: 28203756 Review.
Cited by
-
The Therapeutic Potential of Mesenchymal Stromal Cells in the Treatment of Chemotherapy-Induced Tissue Damage.Stem Cell Rev Rep. 2019 Jun;15(3):356-373. doi: 10.1007/s12015-019-09886-3. Stem Cell Rev Rep. 2019. PMID: 30937640 Review.
-
Peroxisome Proliferator-Activated Receptor-γ Knockdown Impairs Bone Morphogenetic Protein-2-Induced Critical-Size Bone Defect Repair.Am J Pathol. 2019 Mar;189(3):648-664. doi: 10.1016/j.ajpath.2018.11.019. Epub 2018 Dec 26. Am J Pathol. 2019. PMID: 30593824 Free PMC article.
-
Human mesenchymal stem cells are resistant to UV-B irradiation.Sci Rep. 2019 Dec 27;9(1):20000. doi: 10.1038/s41598-019-56591-9. Sci Rep. 2019. PMID: 31882818 Free PMC article.
-
Practical methods for handling human periodontal ligament stem cells in serum-free and serum-containing culture conditions under hypoxia: implications for regenerative medicine.Hum Cell. 2017 Jul;30(3):169-180. doi: 10.1007/s13577-017-0161-2. Epub 2017 Feb 6. Hum Cell. 2017. PMID: 28168362 Free PMC article.
-
Mer or Axl receptor tyrosine kinase inhibition promotes apoptosis, blocks growth and enhances chemosensitivity of human non-small cell lung cancer.Oncogene. 2013 Jul 18;32(29):3420-31. doi: 10.1038/onc.2012.355. Epub 2012 Aug 13. Oncogene. 2013. PMID: 22890323 Free PMC article.
References
-
- He S, Nakada D, Morrison SJ. Mechanisms of stem cell self-renewal. Ann Rev Cell Dev Biol. 2009;25:377–406. - PubMed
-
- Reya T, Morrison SJ, Clarke MF, Weissman IL. Stem cells, cancer, and cancer stem cells. Nature. 2001;414:105–111. - PubMed
-
- Uccelli A, Moretta L, Pistoia V. Mesenchymal stem cells in health and disease. Nat Rev Immunol. 2008;8:726–736. - PubMed
-
- Phinney DG, Prockop DJ. Concise review: mesenchymal stem/multipotent stromal cells: the state of transdifferentiation and modes of tissue repair–current views. Stem Cells. 2007;25:2896–2902. - PubMed
Publication types
MeSH terms
Substances
LinkOut - more resources
Full Text Sources
Research Materials